ANTISENSE-OLIGONUKLEOTIDE ZUR INHIBIERUNG DER TRANSAKTIVATORZIELSEQUENZ (TAR) UND DER SYNTHESE DES TRANSAKTIVATORPROTEINS (TAT) AUS HIV-1 UND DEREN VERWENDUNG
The present invention relates to chemically modified antisense oligonucleotides for inhibiting the transactivator target sequence (TAR) and the synthesis of the transactivator protein (tat) of HIV-1 and to the use thereof in pharmaceuticals. The chemically modified antisense oligonucleotides have an...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LOEBBERDING, ANTONIUS. DR PIEL, NORBERT. DR., 4006 ERKRATH, DE KRETSCHMER, AXEL. DR., 5060 BERGISCH GLADBACH, DE FROMMER, WERNER, DR., 5600 WUPPERTAL, DE KOELBL, HEINZ. DR., WEST HAVEN, CONN., US BAUMGARTEN, JOERG STROPP, UDO-BIO.. DR., 5657 HAAN, DE SPRINGER, WOLFGANG-BIOL. DR., 5600 WUPPERTAL, DE |
| description | The present invention relates to chemically modified antisense oligonucleotides for inhibiting the transactivator target sequence (TAR) and the synthesis of the transactivator protein (tat) of HIV-1 and to the use thereof in pharmaceuticals. The chemically modified antisense oligonucleotides have antiviral effects. The pharmaceuticals can be used for the therapy of HIV infections. The antisense oligonucleotides are suitable as gene probes for detecting HIV. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE3907562A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE3907562A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE3907562A13</originalsourceid><addsrcrecordid>eNqNjbFqAkEURbexCOo_vFKLhagkYjnJ3LgPlzdm3psVtxGRsQoqmO_Jt0YlaaysLgfO4T4VP06MFaIoQ83zIGlRIxh7UJsisVT8xohJ5uQRyaITdQvjxlmILaNWfCZISwNzcUhJ_M3TtVgFxQX0LlrGYGDRa2FDckmp4qYc_bcQahBXEH857RWd_fbrnPt_2y3oA_Zelfl03OTzabvLh_y98ZjMnqcvr2M3mjyg_AIeuETC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTISENSE-OLIGONUKLEOTIDE ZUR INHIBIERUNG DER TRANSAKTIVATORZIELSEQUENZ (TAR) UND DER SYNTHESE DES TRANSAKTIVATORPROTEINS (TAT) AUS HIV-1 UND DEREN VERWENDUNG</title><source>esp@cenet</source><creator>LOEBBERDING, ANTONIUS. DR ; PIEL, NORBERT. DR., 4006 ERKRATH, DE ; KRETSCHMER, AXEL. DR., 5060 BERGISCH GLADBACH, DE ; FROMMER, WERNER, DR., 5600 WUPPERTAL, DE ; KOELBL, HEINZ. DR., WEST HAVEN, CONN., US ; BAUMGARTEN, JOERG ; STROPP, UDO-BIO.. DR., 5657 HAAN, DE ; SPRINGER, WOLFGANG-BIOL. DR., 5600 WUPPERTAL, DE</creator><creatorcontrib>LOEBBERDING, ANTONIUS. DR ; PIEL, NORBERT. DR., 4006 ERKRATH, DE ; KRETSCHMER, AXEL. DR., 5060 BERGISCH GLADBACH, DE ; FROMMER, WERNER, DR., 5600 WUPPERTAL, DE ; KOELBL, HEINZ. DR., WEST HAVEN, CONN., US ; BAUMGARTEN, JOERG ; STROPP, UDO-BIO.. DR., 5657 HAAN, DE ; SPRINGER, WOLFGANG-BIOL. DR., 5600 WUPPERTAL, DE</creatorcontrib><description>The present invention relates to chemically modified antisense oligonucleotides for inhibiting the transactivator target sequence (TAR) and the synthesis of the transactivator protein (tat) of HIV-1 and to the use thereof in pharmaceuticals. The chemically modified antisense oligonucleotides have antiviral effects. The pharmaceuticals can be used for the therapy of HIV infections. The antisense oligonucleotides are suitable as gene probes for detecting HIV.</description><language>ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; DERIVATIVES THEREOF ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; SUGARS ; VINEGAR ; WINE</subject><creationdate>1990</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19900913&DB=EPODOC&CC=DE&NR=3907562A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19900913&DB=EPODOC&CC=DE&NR=3907562A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LOEBBERDING, ANTONIUS. DR</creatorcontrib><creatorcontrib>PIEL, NORBERT. DR., 4006 ERKRATH, DE</creatorcontrib><creatorcontrib>KRETSCHMER, AXEL. DR., 5060 BERGISCH GLADBACH, DE</creatorcontrib><creatorcontrib>FROMMER, WERNER, DR., 5600 WUPPERTAL, DE</creatorcontrib><creatorcontrib>KOELBL, HEINZ. DR., WEST HAVEN, CONN., US</creatorcontrib><creatorcontrib>BAUMGARTEN, JOERG</creatorcontrib><creatorcontrib>STROPP, UDO-BIO.. DR., 5657 HAAN, DE</creatorcontrib><creatorcontrib>SPRINGER, WOLFGANG-BIOL. DR., 5600 WUPPERTAL, DE</creatorcontrib><title>ANTISENSE-OLIGONUKLEOTIDE ZUR INHIBIERUNG DER TRANSAKTIVATORZIELSEQUENZ (TAR) UND DER SYNTHESE DES TRANSAKTIVATORPROTEINS (TAT) AUS HIV-1 UND DEREN VERWENDUNG</title><description>The present invention relates to chemically modified antisense oligonucleotides for inhibiting the transactivator target sequence (TAR) and the synthesis of the transactivator protein (tat) of HIV-1 and to the use thereof in pharmaceuticals. The chemically modified antisense oligonucleotides have antiviral effects. The pharmaceuticals can be used for the therapy of HIV infections. The antisense oligonucleotides are suitable as gene probes for detecting HIV.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>DERIVATIVES THEREOF</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>SUGARS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1990</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjbFqAkEURbexCOo_vFKLhagkYjnJ3LgPlzdm3psVtxGRsQoqmO_Jt0YlaaysLgfO4T4VP06MFaIoQ83zIGlRIxh7UJsisVT8xohJ5uQRyaITdQvjxlmILaNWfCZISwNzcUhJ_M3TtVgFxQX0LlrGYGDRa2FDckmp4qYc_bcQahBXEH857RWd_fbrnPt_2y3oA_Zelfl03OTzabvLh_y98ZjMnqcvr2M3mjyg_AIeuETC</recordid><startdate>19900913</startdate><enddate>19900913</enddate><creator>LOEBBERDING, ANTONIUS. DR</creator><creator>PIEL, NORBERT. DR., 4006 ERKRATH, DE</creator><creator>KRETSCHMER, AXEL. DR., 5060 BERGISCH GLADBACH, DE</creator><creator>FROMMER, WERNER, DR., 5600 WUPPERTAL, DE</creator><creator>KOELBL, HEINZ. DR., WEST HAVEN, CONN., US</creator><creator>BAUMGARTEN, JOERG</creator><creator>STROPP, UDO-BIO.. DR., 5657 HAAN, DE</creator><creator>SPRINGER, WOLFGANG-BIOL. DR., 5600 WUPPERTAL, DE</creator><scope>EVB</scope></search><sort><creationdate>19900913</creationdate><title>ANTISENSE-OLIGONUKLEOTIDE ZUR INHIBIERUNG DER TRANSAKTIVATORZIELSEQUENZ (TAR) UND DER SYNTHESE DES TRANSAKTIVATORPROTEINS (TAT) AUS HIV-1 UND DEREN VERWENDUNG</title><author>LOEBBERDING, ANTONIUS. DR ; PIEL, NORBERT. DR., 4006 ERKRATH, DE ; KRETSCHMER, AXEL. DR., 5060 BERGISCH GLADBACH, DE ; FROMMER, WERNER, DR., 5600 WUPPERTAL, DE ; KOELBL, HEINZ. DR., WEST HAVEN, CONN., US ; BAUMGARTEN, JOERG ; STROPP, UDO-BIO.. DR., 5657 HAAN, DE ; SPRINGER, WOLFGANG-BIOL. DR., 5600 WUPPERTAL, DE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE3907562A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>1990</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>DERIVATIVES THEREOF</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>SUGARS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LOEBBERDING, ANTONIUS. DR</creatorcontrib><creatorcontrib>PIEL, NORBERT. DR., 4006 ERKRATH, DE</creatorcontrib><creatorcontrib>KRETSCHMER, AXEL. DR., 5060 BERGISCH GLADBACH, DE</creatorcontrib><creatorcontrib>FROMMER, WERNER, DR., 5600 WUPPERTAL, DE</creatorcontrib><creatorcontrib>KOELBL, HEINZ. DR., WEST HAVEN, CONN., US</creatorcontrib><creatorcontrib>BAUMGARTEN, JOERG</creatorcontrib><creatorcontrib>STROPP, UDO-BIO.. DR., 5657 HAAN, DE</creatorcontrib><creatorcontrib>SPRINGER, WOLFGANG-BIOL. DR., 5600 WUPPERTAL, DE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LOEBBERDING, ANTONIUS. DR</au><au>PIEL, NORBERT. DR., 4006 ERKRATH, DE</au><au>KRETSCHMER, AXEL. DR., 5060 BERGISCH GLADBACH, DE</au><au>FROMMER, WERNER, DR., 5600 WUPPERTAL, DE</au><au>KOELBL, HEINZ. DR., WEST HAVEN, CONN., US</au><au>BAUMGARTEN, JOERG</au><au>STROPP, UDO-BIO.. DR., 5657 HAAN, DE</au><au>SPRINGER, WOLFGANG-BIOL. DR., 5600 WUPPERTAL, DE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTISENSE-OLIGONUKLEOTIDE ZUR INHIBIERUNG DER TRANSAKTIVATORZIELSEQUENZ (TAR) UND DER SYNTHESE DES TRANSAKTIVATORPROTEINS (TAT) AUS HIV-1 UND DEREN VERWENDUNG</title><date>1990-09-13</date><risdate>1990</risdate><abstract>The present invention relates to chemically modified antisense oligonucleotides for inhibiting the transactivator target sequence (TAR) and the synthesis of the transactivator protein (tat) of HIV-1 and to the use thereof in pharmaceuticals. The chemically modified antisense oligonucleotides have antiviral effects. The pharmaceuticals can be used for the therapy of HIV infections. The antisense oligonucleotides are suitable as gene probes for detecting HIV.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | ger |
| recordid | cdi_epo_espacenet_DE3907562A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DERIVATIVES THEREOF ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS SUGARS VINEGAR WINE |
| title | ANTISENSE-OLIGONUKLEOTIDE ZUR INHIBIERUNG DER TRANSAKTIVATORZIELSEQUENZ (TAR) UND DER SYNTHESE DES TRANSAKTIVATORPROTEINS (TAT) AUS HIV-1 UND DEREN VERWENDUNG |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T21%3A50%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LOEBBERDING,%20ANTONIUS.%20DR&rft.date=1990-09-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE3907562A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |